Skip to content

A multi-center, multi-country, cross-sectional study on the prevalence of ADHD in non-psychotic adult psychiatric care (ADPSYC)

A multi-center, multi-country, cross-sectional study on the prevalence of ADHD in non-psychotic adult psychiatric care (ADPSYC) - Observational Study Protocol B4Z-EW-B020

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38985
Enrollment
240
Registered
2013-04-25
Start date
2013-03-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD - hyperactivity

Interventions

None listed

Sponsors

Eli Lilly
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Male or female outpatients aged between 18 and 65 years attending psychiatric outpatient care - having signed an informed consent to release information prior to any procedure

Exclusion criteria

Exclusion criteria: - Mental disability or disease state to an extent that prevents patients from understanding the nature of the study or that prevents patients from reliably following procedures - Psychotic disorder at presentation or from patient*s history (schizophrenia,schizo-affective, schizophreniform, delusional disorder). Treatment with antipsychotics ,for other indications is not an exclusion criterion. - Have previously been approached or screened for the study

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is to estimate the prevalence of ADHD in non-psychotic adults in psychiatric outpatient care as assessed by the Diagnostic Interview for ADHD in Adults (DIVA) instrument according to DSM-IV criteria.

Secondary

MeasureTime frame
The secondary objectives of the study are as follows: - to characterize the Adult ADHD population as diagnosed by DIVA in terms of symptoms, functioning, quality of life, work status and resource use prior to study entry and also the population of patients without ADHD diagnosis in psychiatric outpatient care - to estimate the prevalence of ADHD in adults in non-psychotic psychiatric outpatient care in different settings and countries or groups of countries with similar mental health organization/health care systems - to estimate the prevalence of ADHD in non-psychotic adults in psychiatric outpatient care based on meeting for example only either 5 or 4 DSM-IV criteria from the attention or hyperactivity/impulsivity symptoms list and with and without the 7- year age limit for childhood onset of symptoms as per DSM-IV, foreseeing the upcoming changes in the next generation of diagnostic criteria - to explore properties of Adult ADHD Self-Report Scale Symptom Checklist ;(ASRS) and/or the ADHD questions of the Provisional Diagnostic Instrument-4 (PDI-4) as derived from ASRS by examining the DIVA item results of patients with various scores on the screening instruments - to estimate the prevalence of other non-psychotic mental disorders in psychiatric care (depression/dysthymia, bipolar disorder, obsessive-compulsive disorder, anxiety disorders, eating disorders, substance/alcohol abuse or dependence, antisocial or borderline personality disorders, autism spectrum disorder) and to estimate their comorbidity with adult ADHD - to provide additional data to support validation of the DIVA.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)